http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10899221

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 3547
issn 1837-9664
issueIdentifier 12
pageRange 3539-3547
publicationName Journal of Cancer
startingPage 3539
bibliographicCitation Lai H, Jiang W, Zhao J, Dinglin X, Li Y, Li S, Wang Y, Yao H. Global Trend in Research and Development of CDK4/6 Inhibitors for Clinical Cancer Therapy: A Bibliometric Analysis. J Cancer. 2021;12(12):3539–47. PMID: 33995631; PMCID: PMC8120189.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_053ae05d92744d49d5753ae8b6a77d05
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_080011f67ff84be10359fbd737e3a48d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a04c21779d753a5be34ec8b2fdeb9064
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16a0f80cb85f32b2490dbc430e41452d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75b943c984abb88efd60755d33070d45
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c2305cd16dae0ee388648bacc0dd06a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_427a25d2bf6af32c214db8236772f0d2
date 2021
identifier https://doi.org/10.7150/jca.51609
https://pubmed.ncbi.nlm.nih.gov/PMC8120189
https://pubmed.ncbi.nlm.nih.gov/33995631
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37885
https://portal.issn.org/resource/ISSN/1837-9664
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Global Trend in Research and Development of CDK4/6 Inhibitors for Clinical Cancer Therapy: A Bibliometric Analysis
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.11.22
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5330286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44631912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46220502

Total number of triples: 31.